(June 2, 2020, 3:40 PM EDT) -- ALEXANDRIA, Va. — In a May 29 petition for inter partes review (IPR), Medtronic Inc. argues that the Patent Trial and Appeal Board should cancel claims 1-8, 13 and 17-22 of...
Medtronic Tells Board Patented Ablation Probe Would Have Been Obvious
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login